Together these results suggest that a HOXA9/MSI2/NUMB pathway is not responsible for CLL-cell proliferation, and identifies control of MSI2 action as a productive avenue of research for the future. This evidence concerns the gene HOXA9 and B-cell chronic lymphocytic leukemia.